Quote | Immatics N.V. (NYSE:IMTX)
Last: | $15.05 |
---|---|
Change Percent: | -1.7% |
Open: | $15.75 |
Close: | $15.05 |
High: | $16.5 |
Low: | $14.62 |
Volume: | 95,850 |
Last Trade Date Time: | 07/03/2020 04:56:45 pm |
News | Immatics N.V. (NYSE:IMTX)
Houston, Texas and Tuebingen, Germany, July 18, 2024 – Immatics N.V. (NASDAQ: IMTX, “Immatics”), a clinical-stage biopharmaceutical company active in the discovery and development of T cell-redirecting cancer immunotherapies, today announced that the first proof-of-conc...
2024-07-12 10:02:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Message Board Posts | Immatics N.V. (NYSE:IMTX)
Subject | By | Source | When |
---|---|---|---|
znewcar1: $IMTX 27% v4,9M c9.33 f76,67M h9.98 ML5.9 | znewcar1 | investorshangout | 05/02/2023 8:37:44 PM |
$IMTX: IMA203 update | FACT-MASTER | investorshub | 05/02/2023 1:09:54 PM |
$IMTX MomentumIts gaining | Solarfuture | investorshub | 05/01/2023 9:52:32 PM |
$IMTX Price trading last up | FACT-MASTER | investorshub | 05/01/2023 3:14:08 PM |
must see | FACT-MASTER | investorshub | 05/01/2023 12:56:02 PM |
News, Short Squeeze, Breakout and More Instantly...
Houston, Texas and Tuebingen, Germany, July 18, 2024 – Immatics N.V. (NASDAQ: IMTX, “Immatics”), a clinical-stage biopharmaceutical company active in the discovery and development of T cell-redirecting cancer immunotherapies, today announced that the first proof-of-conc...
2024-07-12 10:02:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-12 13:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...